CLINICAL_TRIALS
trial_result
· 2019-11-04
Clinical Trial Update: Gabapentin for Alcohol Relapse Prevention [Phase 2]
Summary
Phase 2 trial update evaluating gabapentin for relapse prevention in alcohol use disorder; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medical University of South Carolina | Conditions: Alcohol Use Disorder, Alcohol Withdrawal | Phase 2 | Status: COMPLETED | Results posted: 2019-11-04